Literature DB >> 7492084

Susceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agents.

L J Utrup1, T D Moore, P Actor, J A Poupard.   

Abstract

Neither amoxicillin nor clavulanic acid used alone was active at the highest level tested, i.e., 256.0 micrograms/ml, in vitro against 24 isolates of Mycobacterium fortuitum, Mycobacterium kansasii, and Mycobacterium marinum. However, the MIC of an amoxicillin-clavulanic acid combination of 2:1 was < or = 8.0/4.0 micrograms/ml for 50 percent of the isolates tested, with all isolates being inhibited in the range of 4.0/2.0 to 32.0/16.0 micrograms/ml, respectively. Titration of amoxicillin-clavulanic acid with a fixed 2-micrograms/ml concentration of ethambutol resulted in synergistic activity against 3 of 9 isolates of M. fortuitum, 10 of 10 isolates of M. kansasii, and 5 of 5 isolates of M. marinum. This observation was confirmed in a checkerboard analysis in which fractional inhibitory concentrations were < or = 0.5 for 20 of the 24 isolates. Synergistic activity was observed against the other four isolates in one of two trials. On the other hand, titration of amoxicillin-clavulanic acid in the presence of either one or two fixed concentrations of isoniazid, rifampin, cycloserine, tetracycline, or amikacin failed to result in synergism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492084      PMCID: PMC162761          DOI: 10.1128/AAC.39.7.1454

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  THE NATURE OF MYCOBACTERIAL PENICILLINASE.

Authors:  J E KASIK
Journal:  Am Rev Respir Dis       Date:  1965-01

2.  In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin.

Authors:  M Casal; F Rodriguez; M Benavente; M Luna
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

3.  In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid.

Authors:  M J Casal; F C Rodriguez; M D Luna; M C Benavente
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

4.  Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis.

Authors:  K Takayama; E L Armstrong; K A Kunugi; J O Kilburn
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

5.  In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis.

Authors:  M H Cynamon; G S Palmer
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

6.  Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.

Authors:  J M Swenson; R J Wallace; V A Silcox; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

7.  In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.

Authors:  M H Cynamon; G S Palmer
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

8.  Characterization of beta-lactamases in Mycobacterium fortuitum including a role in beta-lactam resistance and evidence of partial inducibility.

Authors:  D R Nash; R J Wallace; V A Steingrube; T Udou; L C Steele; G D Forrester
Journal:  Am Rev Respir Dis       Date:  1986-12

Review 9.  Spectrum of disease due to rapidly growing mycobacteria.

Authors:  R J Wallace; J M Swenson; V A Silcox; R C Good; J A Tschen; M S Stone
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

10.  The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey.

Authors:  R J O'Brien; L J Geiter; D E Snider
Journal:  Am Rev Respir Dis       Date:  1987-05
View more
  5 in total

Review 1.  A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Authors:  Alain Philippon; Patrick Slama; Paul Dény; Roger Labia
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

2.  Drug effects on intracellular mycobacteria determined by mass spectrometric analysis of the Na(+)-to-K+ ratios of individual bacterial organisms.

Authors:  M Wiese; U Seydel
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 3.  A prolonged case of Mycobacterium marinum flexor tenosynovitis: radiographic and histological correlation, and review of the literature.

Authors:  M D Wongworawat; P Holtom; T J Learch; A Fedenko; M V Stevanovic
Journal:  Skeletal Radiol       Date:  2003-07-22       Impact factor: 2.199

4.  Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death.

Authors:  Roxane Simeone; Alexandre Bobard; Juliane Lippmann; Wilbert Bitter; Laleh Majlessi; Roland Brosch; Jost Enninga
Journal:  PLoS Pathog       Date:  2012-02-02       Impact factor: 6.823

5.  Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening.

Authors:  María Pilar Arenaz-Callao; Rubén González Del Río; Ainhoa Lucía Quintana; Charles J Thompson; Alfonso Mendoza-Losana; Santiago Ramón-García
Journal:  PLoS Negl Trop Dis       Date:  2019-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.